吳 冠諭

Medicine & Life Sciences

1. Prostate 100%
2. Underactive Urinary Bladder 70%
3. Lower Urinary Tract Symptoms 67%
4. Nephroureterectomy 54%
5. Urinary Bladder Neck Obstruction 53%
6. Carcinoma 52%
7. Urodynamics 45%
8. Castration 44%
9. Long Noncoding RNA 43%
10. Laser Therapy 42%
11. Propofol 42%
12. Endoscopy 35%
13. Survivors 34%
14. Urinary Catheterization 33%
15. MicroRNAs 33%
16. Prostatic Neoplasms 31%
17. Population 31%
18. Sleep 31%
19. Overactive Urinary Bladder 30%
20. Meta-Analysis 29%
21. Volatilization 27%
22. Elderly 26%
23. Randomized Controlled Trials 26%
24. Urinary Bladder 25%
25. Inflammation 23%
26. Urinary Retention 18%
27. Survival 18%
28. Injections 18%
29. Neoplasms 17%
30. Pharmaceutical Preparations 16%
31. Confidence Intervals 14%
32. Therapeutics 13%
33. Odds Ratio 12%
34. Urine 11%
35. Multivariate Analysis 10%
36. Kidney Neoplasms 10%
37. Catastrophic Illness 10%
38. Residual Volume 9%
39. Safety 9%
40. Urinary Bladder Neoplasms 8%
41. Patient Rights 8%
42. Doppler Ultrasonography 8%
43. Urinary Tract 7%
44. Epigenomics 7%
45. Treatment Failure 7%